Brief: Krystal Biotech Q1 basic EPS USD -1.76
08/05/2023 13:46
May 8 (Reuters) - Krystal Biotech Q1 operating expenses USD 48.823 million. * Q1 net income USD -45.297 million * Q1 operating income USD -48.823 million * Q1 basic EPS USD -1.76
Recent news on Krystal Biotech
See all newsBrief: Krystal Biotech Announces Positive Clinical Data For New Dermatology Program KB113 Demonstrating Broad Basal Cell Carcinoma Regression In Patients With Gorlin Syndrome
Krystal Biotech Inc reports results for the quarter ended June 30 - Earnings Summary
Krystal Biotech Q2 revenue rises on VYJUVEK strength
Brief: Krystal Biotech - Files Response With Uspto On Kb801 Patent Application - SEC Filing
Construction firm Tutor Perini jumps on S&P SmallCap inclusion